(19)
(11) EP 4 536 841 A2

(12)

(88) Date of publication A3:
25.01.2024

(43) Date of publication:
16.04.2025 Bulletin 2025/16

(21) Application number: 23738131.4

(22) Date of filing: 09.06.2023
(51) International Patent Classification (IPC): 
C12P 19/04(2006.01)
C12N 9/10(2006.01)
C12P 19/18(2006.01)
(52) Cooperative Patent Classification (CPC):
C12P 19/04; C12P 19/18; C12N 9/1051; C12N 9/1074; C12Y 204/01001; C12Y 204/01004; C12Y 204/01007; C12Y 204/01019
(86) International application number:
PCT/IB2023/055978
(87) International publication number:
WO 2023/238100 (14.12.2023 Gazette 2023/50)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 10.06.2022 WO PCT/CN2022/098225

(71) Applicant: Beren Therapeutics P.B.C.
West Hollywood, CA 90069 (US)

(72) Inventors:
  • GROBAN, Eli
    San Francisco, California 94118 (US)
  • HU, Karl
    Jiangsu 215600 (CN)
  • PFEIFFER, Steven
    Hollywood, CA 90069 (US)
  • RIZKIN, Benjamin
    Hollywood, CA 90069 (US)
  • BENKOVICS, Gabor
    Hollywood, California 90069 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) METHODS FOR PRODUCING ALPHA-CYCLODEXTRINS